REED ELIZABETH E (SVP, GC & Corporate Secretary) sold 2.8% of their position (2.99K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $96.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/5/2026ACC: 0001283303-26-000003
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
-2.99K
Net shares
Net seller
$96.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.99K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.48K
Price / share
$32.07
Trade value
$79.69K
% of position
2.3%
2/4/2026
108.20K→105.72K
Common Stock
Direct
Shares
−509.00
Price / share
$32.74
Trade value
$16.66K
% of position
0.5%
2/4/2026
105.72K→105.21K
Total
Net shares
−2.99K
Net value
-$96.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | S · Sale | −2.48K | $32.07 | $79.69K | 2.3% | 108.20K | 105.72K |
| Common Stock Direct | 2/4/2026 | S · Sale | −509.00 | $32.74 | $16.66K | 0.5% | 105.72K | 105.21K |
| Total | −2.99K | -$96.36K | ||||||
Derivative Transactions0
No derivative transactions reported